China NMPA Inspection - Changchun Botai Pharmaceutical Biotechnology Co., Ltd. - April 26, 2019

On April 26, 2019, the Jilin Provincial Drug Administration issued a public proposal to grant a Cosmetics Production License to Changchun Botai Pharmaceutical Biotechnology Co., Ltd. This decision followed an on-site inspection and comprehensive review conducted by the administration, confirming the company's adherence to the regulatory requirements. The inspection process was guided by the former State Food and Drug Administration's "Notice on Further Improving the Current Work Related to Cosmetics Production Licensing." The company, located at No. 1050, Guanggu Street, High-tech Zone, Changchun City, sought licensing for the production of general liquid unit cosmetics, specifically skin care water. The document identified Liu Tao as the legal representative and enterprise person in charge, with Sun Shujuan overseeing quality. Significantly, no main violations or issues were identified during the review that would hinder the license issuance, indicating compliance with manufacturing standards. As a final step, the proposal was publicized for a five-working-day period, inviting public supervision before the official license is issued by the Jilin Provincial Drug Administration, ensuring transparency and accountability in the regulatory process.